Alerts will be sent to your verified email
Verify Email
MAHAREM
|
IndoAmerican Advance
|
Kimia Biosciences
|
Coral Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-12.16 % | -335.15 % | 8.16 % |
|
5yr average Equity Multiplier
|
1.07 | 66.02 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 1.14 | 0.47 |
|
5yr Avg Net Profit Margin
|
-36.65 % | -0.67 % | 14.82 % |
|
Price to Book
|
n/a | 16.56 | 0.88 |
|
P/E
|
n/a | 17.11 | 9.87 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -33.97 Days | 35.5 Days |
|
Inventory Days
|
0.0 | 101.63 Days | 69.25 Days |
|
Days Receivable
|
0.0 | 98.68 Days | 98.13 Days |
|
Days Payable
|
167.71 Days | 171.28 Days | 131.4 Days |
|
5yr Average Interest Coverage Ratio
|
-55.68 | 0.78 | 171.88 |
|
5yr Avg ROCE
|
-12.15 % | 10.6 % | 10.48 % |
|
5yr Avg Operating Profit Margin
|
-72.03 % | 3.89 % | 14.88 % |
|
5 yr average Debt to Equity
|
0.0 | 29.85 | 0.02 |
|
5yr CAGR Net Profit
|
n/a | 13.51 % | 12.26 % |
|
5yr Average Return on Assets
|
-11.02 % | -0.69 % | 6.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.97 % | 74.94 % | 71.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.4 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
IndoAmerican Advance
|
Kimia Biosciences
|
Coral Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|